Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NACDS Releases Poll: 70% of Adults Back Extension of Policies Giving Access to Pharmacies' Pandemic Services

The National Association of Chain Drug Stores is urging the Biden Administration to ensure clarity or to act decisively to extend PREP Act authorities that have served Americans well, and that Americans do not want to see rolled back


News provided by

National Association of Chain Drug Stores

Mar 14, 2022, 07:45 ET

Share this article

Share toX

Share this article

Share toX


ARLINGTON, Va., March 14, 2022 /PRNewswire-PRWeb/ -- The National Association of Chain Drug Stores (NACDS) today released poll results that show significant support for extending the policies that have allowed Americans to access essential services from their pharmacies during the pandemic.

NACDS has urged the Biden Administration to provide clarity or to take definitive action to ensure Americans maintain access to pharmacy services that will remain essential when the current public health emergency (PHE) concludes. These services – made possible under an array of amendments to the current declaration of the Public Readiness and Emergency Preparedness (PREP) Act – relate to COVID-19 tests, vaccinations and therapeutics; childhood vaccinations; and flu vaccinations.

Americans do not want to see a roll-back of the access to convenient, trusted and equitable pharmacy services. NACDS urges action to ensure Americans can continue to rely on their pharmacies and pharmacy teams and so we as a nation can remain prepared for whatever lies ahead.

Post this

The poll – conducted by Morning Consult and commissioned by NACDS – surveyed American adults from March 4 to 6. Regarding the set of national policies that were put into place to allow pharmacists and pharmacy teams to provide pandemic-related services:

  • 70% support extending these policies
  • 68% support making these policies permanent.

Those who received a COVID-19 vaccination from a pharmacy are even more supportive. Among those who received their COVID-19 booster at a pharmacy:

  • 85% support extending these policies
  • 84% support making these policies permanent.

NACDS says these results bolster the urgent need for attention and response to its February 25 letter to Secretary of Health and Human Services Xavier Becerra and White House COVID-19 Response Team Coordinator Jeffrey Zients. In that letter, NACDS urged clarity that PREP Act pharmacy authorities will not be impacted by a lifting of the PHE, or an extension of the PREP Act declaration based on the sustained credible risk of a PHE.

"The loss of pharmacy-related PREP Act declaration allowances would impede the equitable access to care that Americans have received from pharmacy during the pandemic," wrote NACDS President and Chief Executive Officer Steven C. Anderson.

Anderson explained, "While optimism is mounting, and may be warranted, for a potential end of the currently declared public health emergency, it is important that the access to care Americans have come to rely on and expect at pharmacies is maintained. Pharmacies have demonstrated their importance as an access point, and remain vital to continue meeting Americans' needs and protecting health and wellness, especially as the nation navigates the potential transition from pandemic to endemic. Importantly, long-term solutions are needed as lessons learned from this pandemic demand the nation establish flexible, scalable, and sustainable access to vaccinations, testing, and other pandemic-related care for Americans at pharmacies now and permanently for future public health crises."

This issue also is gaining attention on Capitol Hill. At a March 2 hearing of the Oversight and Investigations Subcommittee of the U.S. House of Representatives Energy and Commerce Committee, Ranking Member Morgan Griffith (R-VA) said: "Emergency flexibilities implemented by federal and state government also helped increase patient access to healthcare – such as allowing pharmacists to deliver vaccines and allowing hospitals to compound medications that were in short supply. As we move forward, this Committee should examine which of these flexibilities should be available on a permanent basis."

The Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report published March 11 further validates the need to prevent patient-access rollbacks. It states: "Broad vaccine access should be maintained while critical outreach efforts continue to improve vaccine coverage among children aged 5-11 years, especially in SVI [high social vulnerability] areas."

The authors also note: "The expansion of legal authorities for the COVID-19 emergency response to allow pharmacists to vaccinate children and adolescents aged 3-18 years helped increase available providers and vaccine access for children aged 5-11 years. Pharmacy providers were critical in addressing high initial demand for COVID-19 vaccine among this age group, including during evenings, weekends, and over holidays, when other providers might be less available."

Among additional findings of the poll results that NACDS released today, majorities of adults say extending the policies would have a mostly positive effect on each of the following:

  • lowering COVID-19 hospitalization rates
  • lowering COVID-19 deaths
  • lowering COVID-19 cases
  • ability to find COVID-19 symptom care
  • health equity
  • convenience of routine vaccinations
  • convenience of tests for illnesses
  • quality of healthcare services available
  • patient ability to catch up on missed vaccines due to the pandemic.

Majorities of adults also indicated they find concerning these potential negative outcomes of not extending the policies:

  • limited access to vaccines for COVID-19 and the flu
  • limited access to testing for COVID-19 and the flu
  • slower rollout of potential future COVID-19 booster shots
  • slower response time for future COVID-19 variants
  • inconsistent policies for patients in different states
  • inequity in access for patients in different states.

"Americans do not want to see a roll-back of the access to convenient, trusted and equitable pharmacy services," Anderson said. "We urge action to ensure Americans can continue to rely on their pharmacies and pharmacy teams and so we as a nation can remain prepared for whatever lies ahead."

NACDS emphasizes government statistics that demonstrate the importance of pharmacy's role in the pandemic response. Pharmacies provide more than two of every three COVID-19 vaccine doses. More than 30% of children ages 5 to 11 who have received their COVID-19 vaccination have done so at a pharmacy. Half of pharmacy COVID-19 vaccination sites are located in areas with high social vulnerability, and 70% of pharmacy testing sites are in areas with moderate to severe social vulnerability. More than 40% of those vaccinated at pharmacies are from racial and ethnic minority groups.

More information – including detailed reports of lessons learned and recommendations from the pandemic – is available at NACDS.org/COVID-19.

###

NACDS represents traditional drug stores, supermarkets and mass merchants with pharmacies. Chains operate over 40,000 pharmacies, and NACDS' over 80 chain member companies include regional chains, with a minimum of four stores, and national companies. Chains employ nearly 3 million individuals, including 155,000 pharmacists. They fill over 3 billion prescriptions yearly, and help patients use medicines correctly and safely, while offering innovative services that improve patient health and healthcare affordability. NACDS members also include more than 900 supplier partners and over 70 international members representing 21 countries. Please visit NACDS.org

Media Contact

Kathleen Bashur, National Association of Chain Drug Stores, (703) 837-4367, [email protected]

SOURCE National Association of Chain Drug Stores

Modal title

Adults who received a COVID-19 vaccine dose at a pharmacy are even more likely to back the extension of policies that enhance access to pharmacy pandemic-related services.
View PDF
Adults who received a COVID-19 vaccine dose at a pharmacy are even more likely to back the extension of policies that enhance access to pharmacy pandemic-related services.
Adults who received a COVID-19 vaccine dose at a pharmacy are even more likely to back the extension of policies that enhance access to pharmacy pandemic-related services.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.